22157.jpg
Global Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Devices Pipeline Report 2021: Product Description, Licensing and Collaboration Details, Developmental Activities
November 05, 2021 10:33 ET | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has...
22157.jpg
The Worldwide Balloon Catheters Industry is Expected to Reach $5.1+ Billion by 2026
September 07, 2021 05:18 ET | Research and Markets
Dublin, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The "Balloon Catheters Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global balloon catheters...
22157.jpg
Global and China PTA Balloon Catheter Markets Report 2021: Analysis & Forecasts, 2016-2020 & 2021-2026
May 19, 2021 07:28 ET | Research and Markets
Dublin, May 19, 2021 (GLOBE NEWSWIRE) -- The "Global and Chinese Pta Balloon Catheter Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com's offering. 'Global and...
22157.jpg
Global PTA Balloon Catheters Device Pipeline Assessment 2020: Stage of Development / Segment / Territory / Regulatory Path / Estimated Approval Date / Ongoing Clinical Trials
December 23, 2020 03:58 ET | Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "PTA Balloon Catheters - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "PTA Balloon...
BBRAUN SE_GREEN (1).jpg
B. Braun Interventional Systems Receives Breakthrough Device Designation Status from the FDA for SeQuent Please ReX Drug Coated PTCA Balloon Catheter
August 01, 2019 09:00 ET | B. Braun Medical Inc.--US
BETHLEHEM, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
Lubrizol expands its medical device design, development, and manufacturing capabilities with the acquisition of Bavaria Medizin Technologie GmbH.
Lubrizol übernimmt die Bavaria Medizin Technologie GmbH
July 15, 2019 02:00 ET | Lubrizol
CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- Die Lubrizol Corporation gibt die Übernahme der Bavaria Medizin Technologie GmbH (BMT), eines innovativen Entwicklers und Herstellers von intravaskulären...
Lubrizol expands its medical device design, development, and manufacturing capabilities with the acquisition of Bavaria Medizin Technologie GmbH.
Lubrizol Acquires Bavaria Medizin Technologie GmbH
July 15, 2019 02:00 ET | Lubrizol
CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- The Lubrizol Corporation announces the acquisition of Bavaria Medizin Technologie GmbH (BMT), an innovative designer and manufacturer of both...